STOCKWATCH
·
Pharmaceuticals
Quarterly Result12 Aug 2025, 01:09 pm

Granules India Q1FY26 Revenue Up 3% YoY, Net Profit Down 16% YoY

AI Summary

Granules India Ltd., a vertically integrated pharmaceutical company, announced its financial results for the quarter ended June 30, 2025. The company reported a revenue from operations of INR 12,101 Mn, a growth of 3% YoY. The EBITDA for the quarter stood at INR 2,467 Mn, down 5% YoY. The PBT stood at INR 1,704 Mn, down 6% YoY, and the PAT stood at INR 1,126 Mn, down 16% YoY. The company's net debt stood at INR 9,480 Mn and the net debt to EBITDA ratio was 0.96x.

Key Highlights

  • Revenue from operations for Q1FY26 stood at INR 12,101 Mn, a growth of 3% YoY.
  • EBITDA for Q1FY26 stood at INR 2,467 Mn, down 5% YoY.
  • PBT for Q1FY26 stood at INR 1,704 Mn, down 6% YoY.
  • PAT for Q1FY26 stood at INR 1,126 Mn, down 16% YoY.
  • Net debt stood at INR 9,480 Mn and net debt to EBITDA ratio was 0.96x.
GRANULES
Pharmaceuticals
GRANULES INDIA LTD.-$

Price Impact